ArticleFrontiers in immunology2023

Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor.

Guo-Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.